8 Stories of Lab Safety Gone Wrong

List

Read about eight incidents from which we can all learn important lessons about lab safety.

Read more

Ingestible Drug-Delivery Materials May Improve Patient Treatment Compliance

News

Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.

Read more

Analyze Glycans Up To 5X Faster than HILIC

Video

Obtaining high resolution glycan data has traditionally required patience. Typical analysis methods can take up to a full day. Not any longer. SCIEX Fast Glycan Labeling and Analysis delivers rapid glycan heterogeneity identification, capable of profiling your glycans in record time. Combining simplified sample preparation, rapid separations and automated glycan identification, you can make confident decisions quickly by running glycans up to five-times faster than HILIC.

Watch Now

NIH links Aldosterone to Alcohol Use Disorder

News

National Institutes of Health study demonstrates that aldosterone, a hormone produced in the adrenal glands, may contribute to alcohol use disorder (AUD)

Read more
Researchers Develop New Method to Generate Human Antibodies

Researchers Develop New Method to Generate Human Antibodies

News

Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.

Read more
 
Hypothalamic Stem Cells Control Speed of Ageing
News

Researchers have found that stem cells in the brain’s hypothalamus govern how fast aging occurs in the body, which could lead to new strategies for warding off age-related diseases and extending lifespan.

Read more

FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia
News

TheFDA has changed its accelerated approval of blinatumomab (Blincyto®) for some patients with acute lymphoblastic leukemia to a full approval and expanded the approved indications for its use.

Read more

Shedding Light on How Tumors Become Resistant to Immunotherapy
News

Researchers have now found that in skin cutaneous melanoma an epigenetic control protein is key to the development of immunotherapy resistance.

Read more